用免疫检查点抑制剂治疗的癌症患者的血清自身抗体概况:一个横截面研究

Kun Chen1, Bao'e Guo1, Rufeng Liu1

  • 1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Clinical Laboratory, Peking University Cancer Hospital & Institute, Beijing, China.

Frontiers in oncology
|December 10, 2025
PubMed
概括

癌症患者的自身抗体 (AAb) 水平高于健康个体. 免疫检查点抑制剂 (ICI) 治疗增加了抗核抗体 (ANA) 患病率,特别是CTLA-4抑制剂,这表明AAb分析有助于免疫治疗监测.